Mechanisms of Immune Modulation by Abscisic Acid
Mechanisms of Immune Modulation by Abscisic Acid
批准号:
7680243
负责人:
Josep Bassaganya-Riera
金额:
$32.34万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-01 至 2011-08-31
关键词:
Abscisic AcidAcidsAdolescentAgonistAnimalsAntigensAuxinsBacterial AntigensBindingBiological AssayBotanicalsCarotenoidsCellsCommunicable DiseasesComplement Factor BComplexConjugated Linoleic AcidsControl LocusDeltastabDevelopmentDinoprostoneDocosahexaenoic AcidsFamily suidaeFlowersGenetic TranscriptionGlucoseGoalsGrowthHealthImmuneImmune responseIn VitroInfectionInflammationInflammatoryIsomerismJurkat CellsLaboratoriesLigandsLungLymphocyteMediatingMembraneMessenger RNAModelingMolecularMolecular TargetMonocyte Chemoattractant Protein-1MusNuclearNuclear ReceptorsNutrientOrganismPathologyPeroxisome Proliferator-Activated ReceptorsPlant Growth RegulatorsPlantsPneumoniaProductionProliferatingPropertyProstaglandinsRegulationReporterRespiratory syncytial virusRoleSecondary toSeverity of illnessSolutionsSpecificityStagingT-Cell ProliferationT-LymphocyteTestingTimeTranscriptional RegulationVaccinatedVaccinationViralVirus Diseasesbasebiological adaptation to stresschemokinecytokineenantiomerfeedinggastrointestinalimmune functionimmunoregulationimprovedin vivoinfluenzavirusinhibitor/antagonistlymph nodeslymphocyte proliferationmRNA Expressionmacrophagemortalitynovelpathogenplant growth/developmentprotein expressionreceptorreproductiverespiratoryresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Abscisic acid (ABA) is a botanical involved in the regulation of plant growth and a promising immune modulator. ABA activates peroxisome proliferator-activated receptor?? (PPAR ??) in reporter assays and modulates immune function and inflammation in vivo. The long-term goal of this application is to elucidate the cellular and molecular mechanisms by which ABA modulates immune function. Specific Aim 1 will test the hypothesis that ABA modulates lymphocyte proliferation through a PPAR? -dependent mechanism. To test this hypothesis we will: 1) Investigate the ability of ABA's isomers and enantiomers to activate PPAR? in reporter assays in Jurkat cells; 2) Evaluate the specificity of pure ABA enantiomers as PPAR? ligands in binding assays; 3) Use the most effective PPAR? -activating enantiomer for mechanistic studies in vivo to determine whether the expression of PPAR? in immune cells is required for ABA's immunoregulatory actions in influenza virus-vaccinated mice; and 4) Investigate whether the effects of ABA on antigen-specific T cell responses to influenza virus vaccination are secondary to suppression of macrophage-derived PGE2. Monocyte chemoattractant protein-1 (MCP-1) is a chemokine that contributes to the debilitating effects in the host during influenza virus infections. Interestingly, ABA suppresses macrophage MCP-1 mRNA and protein expression. Nuclear factor-?B (NF-?B) is a.central inducer of MCP-1 transcription. Specific Aim 2 will test the hypothesis that ABA down-modulates MCP-1 production through a PPAR?-mediated blockade of NF-?B. Specific aim 2 will dissect the mechanisms of transcriptional regulation of MCP-1 expression by ABA. Specifically, we will: 1) Determine the influence of ABA treatment on the DMA-binding activity of NF-?B in macrophages; 2) Investigate whether ABA represses the expression of NF-?B subunits or induces I?B??expression under inflammatory conditions; 3) Assess the physical interaction of ABA-activated PPAR? and RelA and its role in inhibiting MCP-1 expression in macrophages; and 4) Determine if ABA suppresses the pulmonary inflammatory pathology and MCP-1 expression in the lungs of influenza virus-infected mice by activating PPAR? and inhibiting NF-?B. The mechanistic understanding of the immune modulatory properties of botanicals such as ABA will aid in the development of more efficacious CAM approaches for modulating immune function and ameliorating infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel first-in-class Therapeutics for Rheumatoid Arthritis
-
批准号:10696749
-
项目类别:
-
资助金额:$29.59万
-
财政年份:2023
-
负责人:Josep Bassaganya-Riera
-
依托单位:
Targeting the Immunometabolic Hub Nlrx1 as a Novel Therapeutic for Asthma
-
批准号:10323994
-
项目类别:
-
资助金额:$36.15万
-
财政年份:2021
-
负责人:Josep Bassaganya-Riera
-
依托单位:
The First Abscisic Acid-Containing Medical Food for Glycemic Control
-
批准号:9199816
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2016
-
负责人:Josep Bassaganya-Riera
-
依托单位:
Development of Novel LANCL2-based Anti-diabetic Compounds
-
批准号:8644667
-
项目类别:
-
资助金额:$18.83万
-
财政年份:2013
-
负责人:Josep Bassaganya-Riera
-
依托单位:
Modeliing immunity for Biodefense:Enteroagressive E. coli and Helicobacter pylori
-
批准号:8159584
-
项目类别:
-
资助金额:$1057.19万
-
财政年份:2010
-
负责人:Josep Bassaganya-Riera
-
依托单位:
Modeliing immunity for Biodefense:Enteroagressive E. coli and Helicobacter pylori
-
批准号:9119579
-
项目类别:
-
资助金额:$150.0万
-
财政年份:2010
-
负责人:Josep Bassaganya-Riera
-
依托单位:
Mechanisms of Immune Modulation by Abscisic Acid
-
批准号:7334576
-
项目类别:
-
资助金额:$29.1万
-
财政年份:2007
-
负责人:Josep Bassaganya-Riera
-
依托单位:
Mechanisms of Immune Modulation by Abscisic Acid
-
批准号:7920822
-
项目类别:
-
资助金额:$28.91万
-
财政年份:2007
-
负责人:Josep Bassaganya-Riera
-
依托单位:
Mechanisms of Immune Modulation by Abscisic Acid
-
批准号:7484315
-
项目类别:
-
资助金额:$28.73万
-
财政年份:2007
-
负责人:Josep Bassaganya-Riera
-
依托单位:
国内基金
海外基金
登录
查看更多内容
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: